Matches in Wikidata for { <http://www.wikidata.org/entity/Q86260279> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q86260279 description "clinical trial" @default.
- Q86260279 description "ensayu clínicu" @default.
- Q86260279 description "klinisch onderzoek" @default.
- Q86260279 description "клінічне випробування" @default.
- Q86260279 name "Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 name "Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 type Item @default.
- Q86260279 label "Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 label "Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 prefLabel "Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 prefLabel "Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 P1050 Q86260279-AAB6F8E0-AC28-4BF0-80F0-4D4784E32D22 @default.
- Q86260279 P1132 Q86260279-D6AFE833-0B83-46DC-9DF9-512DF9A3B9CE @default.
- Q86260279 P1476 Q86260279-666843F0-935E-4C74-BED1-A8D837DA4EA3 @default.
- Q86260279 P17 Q86260279-5835200E-917B-4E7C-AE4A-3001A4D1989A @default.
- Q86260279 P1813 Q86260279-1C661458-3CDA-4E8D-9E75-7B4EFF77E0C2 @default.
- Q86260279 P2899 Q86260279-16DD7C2D-0C2C-46F8-8349-85A2376B0173 @default.
- Q86260279 P3098 Q86260279-F8C8434E-C032-4835-945C-D770E1AF7C70 @default.
- Q86260279 P31 Q86260279-E0F1AD1B-B31A-489C-839F-5CC63B1408EB @default.
- Q86260279 P4844 Q86260279-1A80F33B-1813-4116-8CCC-BFBAC83D8874 @default.
- Q86260279 P4844 Q86260279-31628589-F03F-478B-8B06-4B542CA82C2C @default.
- Q86260279 P4844 Q86260279-3E3AFB55-B21F-4FA4-AFCA-FF7EB6820F6A @default.
- Q86260279 P4844 Q86260279-88F33F6E-A2C8-4991-BD5A-57A795458C10 @default.
- Q86260279 P4844 Q86260279-B72F3C9C-BFB1-4B53-9641-387FAA3F86AA @default.
- Q86260279 P4844 Q86260279-DD917A0D-34DE-45FD-A189-2E2FBC42C179 @default.
- Q86260279 P580 Q86260279-54A609C0-3BE9-4B51-806E-844F15B9007D @default.
- Q86260279 P582 Q86260279-6B4388CB-A145-459F-B4BF-85B08DB424ED @default.
- Q86260279 P6099 Q86260279-FCD8733F-4495-4736-88B1-B9C693761DDA @default.
- Q86260279 P8363 Q86260279-3AE56524-78C5-49A7-8322-78A77909E9DA @default.
- Q86260279 P1050 Q467635 @default.
- Q86260279 P1132 "+6" @default.
- Q86260279 P1476 "Pilot Study (Phase II) of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib" @default.
- Q86260279 P17 Q29 @default.
- Q86260279 P1813 "POCODEX" @default.
- Q86260279 P2899 "+18" @default.
- Q86260279 P3098 "NCT04243109" @default.
- Q86260279 P31 Q30612 @default.
- Q86260279 P4844 Q15889608 @default.
- Q86260279 P4844 Q203174 @default.
- Q86260279 P4844 Q408524 @default.
- Q86260279 P4844 Q419319 @default.
- Q86260279 P4844 Q425681 @default.
- Q86260279 P4844 Q7227206 @default.
- Q86260279 P580 "2017-02-23T00:00:00Z" @default.
- Q86260279 P582 "2019-05-07T00:00:00Z" @default.
- Q86260279 P6099 Q42824440 @default.
- Q86260279 P8363 Q78089383 @default.